Regeneron Pharmaceuticals

Latest statistics and disclosures from Regeneron Pharmaceuticals's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are NTLA, Adicet Bio, and represent 100.00% of Regeneron Pharmaceuticals's stock portfolio.
  • Regeneron Pharmaceuticals has $48M in assets under management (AUM), dropping by 41.67%.
  • Central Index Key (CIK): 0000872589

Tip: Access up to 7 years of quarterly data

Positions held by Regeneron Pharmaceuticals consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Regeneron Pharmaceuticals

Regeneron Pharmaceuticals holds 2 positions in its portfolio as reported in the March 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Intellia Therapeutics Common Stock (NTLA) 99.1 $48M 3.7M 12.82
 View chart
Adicet Bio Common Stock 0.9 $412k 61k 6.81
 View chart

Past Filings by Regeneron Pharmaceuticals

SEC 13F filings are viewable for Regeneron Pharmaceuticals going back to 2024